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AbstrACt
Objective To explore the role of the novel cardiac output 
response to stress (CORS), test in the current diagnostic 
pathway for heart failure and the opportunities and 
challenges to potential implementation in primary care.
Design Qualitative study using semistructured in-depth 
interviews which were audio recorded and transcribed 
verbatim. Data from the interviews were analysed 
thematically using an inductive approach.
setting Newcastle upon Tyne, UK.
Participants Fourteen healthcare professionals (six 
males, eight females) from primary (general practitioners 
(GPs), nurses, healthcare assistant, practice managers) 
and secondary care (consultant cardiologists).
results Four themes relating to opportunities and 
challenges surrounding the implementation of the new 
diagnostic technology were identified. These reflected 
that the adoption of CORS test would be an advantage to 
primary care but the test had barriers to implementation 
which include: establishment of clinical utility, suitability for 
immobile patients and cost implication to GP practices.
Conclusion The development of a simple non-invasive 
clinical test to accelerate the diagnosis of heart failure 
in primary care maybe helpful to reduce unnecessary 
referrals to secondary care. The CORS test has the 
potential to serve this purpose; however, factors such as 
cost effectiveness, diagnostic accuracy and seamless 
implementation in primary care have to be fully explored.
IntrODuCtIOn  
Heart failure (HF) is a complex clinical 
syndrome resulting from impaired heart 
function.1 2 It is recognised globally as a chal-
lenging public health burden and is character-
ised by debilitating symptoms for the patient, 
including breathlessness, oedema and 
fatigue and often coexists with other comor-
bidities.3 Signs and symptoms are non-spe-
cific and therefore difficult for primary care 
physicians to produce an accurate diagnosis 
and referral.4 Increasing ageing population 
and improved outcomes in acute coronary 
syndrome have led to a growing incidence 
and prevalence of HF.
Early diagnosis of HF is crucial to improve 
survival, reduce hospitalisation and costs.1 5 
Primary care represents the first point of care 
in the clinical care pathway (figure 1) for 
patients presenting with symptoms of HF and 
general practitioners (GPs) play a crucial role 
in early identification6 7 of patients. Evalua-
tion of patients begin with a detailed medical 
history and performance of diagnostics tests. 
The diagnostic tests currently available to 
GPs include ECG8), and serum natriuretic 
peptides (N-terminal prohormone of brain 
natriuretic peptide [NT-proBNP]) tests. 
ECGs are insufficiently sensitive to detect 
HF and NT-proBNP test is only accurate as 
a test to exclude HF diagnosis; however, the 
later test can lead to a significant number 
of false positives due to its low specificity.9–11 
This has resulted in an unnecessary increase 
strengths and limitations of this study
 ► We have recently developed a novel cardiac output 
response to stress (CORS) test which has potential 
to improve diagnostic accuracy of heart failure in 
primary care.
 ► The interviews with 14 primary and secondary 
healthcare professionals allowed exploration of the 
opportunities and challenges for the implementation 
of the CORS test.
 ► Study participants were recruited from one geo-
graphic region, that is, the North of England.
 ► No patients were interviewed.
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in referrals of patients to secondary care as >65% of 
suspected patients with HF referred from primary to 
secondary care do not have diagnosis confirmed following 
echocardiography and specialist review.4 8 12 13 This creates 
undue worry for the patients as there is a delay in care of 
patients with the average waiting time for investigation 
being 67 days.14 This also poses unnecessary financial and 
human resource burden to secondary care providers as 
time and resources could have been used more effectively 
for patients who need the attention of secondary care 
specialists.1 2 15
We have recently developed and confirmed accept-
able reproducibility of a novel, easy-to-use, non-invasive 
cardiac output response to stress (CORS) test (figure 2) 
for the evaluation of cardiac function in primary care.16 
The CORS test has the potential to be used by health-
care professionals to improve diagnostic accuracy for 
suspected HF and provide an objective measure of 
cardiac function as a ‘rule in’ test. Prior to conducting 
a large trial on further effectiveness of the CORS test, it 
was important to understand how primary and secondary 
healthcare professionals perceive this new diagnostic test. 
Information from healthcare providers would help us 
understand if there was a relevance of the CORS test and 
also help us make better judgement on the design of a 
larger trial if we thought this was plausible. The objectives 
of this study were first to explore the role of the CORS test 
in the current clinical care pathway for suspected HF, and 
Figure 1 Current clinical pathway for suspected heart failure (HF) diagnosis described by healthcare professionals in this study 
and adopted from the guidelines from the National Institute for Health and Care Excellence for Chronic Heart Failure.2 3 CORS, 
cardiac output response to stress; GP, general practitioner; NT-proBNP, N-terminal prohormone of brain natriuretic peptide.  o
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second to identify the potential opportunities and chal-
lenges to potential implementation in care of patients.
MethODs
study design, setting and participants
Semistructured in-depth interviews (14 in total; table 1) 
were conducted between December 2017 and April 2018 
in the North of England. Participants were purposely 
selected according to their role and involvement in 
the management of patients with suspected or diag-
nosed HF in both primary and secondary care. Potential 
interviewees were sent an email invitation which briefly 
outlined the aims of the study. Those agreeing to partic-
ipate were invited to recommend additional candidates 
for interview. Data were collected at the workplace of 
study participants. All interviews were digitally recorded, 
anonymised and transcribed in full.
One research associate (SC) conducted the fieldwork
Interviews were typically around 60 min in length and 
conducted on an individual, face-to-face basis. The final 
sample is described in table 1. First, participants were 
asked questions on the current clinical care pathway for 
HF. Then, a video demonstration of a patient completing 
the CORS test was shown with an explanation of each 
phase of the test provided by the interviewer (duration: 
02:41 min). Finally, questions were asked about the CORS 
test and potential barriers and facilitators to its imple-
mentation. Examples of questions asked which relate to 
the main objectives of the study include: (1) Does the 
current clinical care pathway lead to you seeing many 
patients who are unlikely to receive a HF diagnosis in 
secondary care? (2) Do the referral time from suspected 
HF diagnosis in primary care to confirmed diagnosis 
need to be improved? (3) What are your thoughts about 
this potential improvement in diagnosis being imple-
mented in the clinical care pathway for HF? (4) Where 
in the clinical care pathway for suspected HF diagnosis 
would you expect this test to be performed? (5) Do you 
anticipate any immediate barriers to implementing this 
test as part of your routine clinical care for a patient with 
a suspected HF diagnosis in your practice? Prompts were 
used generate a deeper understanding of participants’ 
views about the questions asked (see online supplemen-
tary appendix for full list of interview questions and 
prompts).
Figure 2 Cardiac output response to stress test. The 
cardiac output response to stress test consists of three 
phases: rest, challenge and stress exercise. Each phase 
lasts for 3 min, and stress phase integrates additional 3 min 
to increase intensity and metabolic demand (from 10 to 15 
steps/min).
Table 1 List of interviewees
Organisation No of interviews Interviewee Sex Years in practice Practice list size
Practice 1 2 GP
Practice manager
M
M
40
2
5512
Practice 2 3 GP
Practice nurse
Practice manager
M
F
F
15
15
2
5140
Practice 3 1 GP F 26 6491
Practice 4 2 GP
Healthcare assistant
M
F
25
13
11 091
Community setting 3 Heart failure specialist nurse F 13, 5, 17
Hospital site 3 Consultant cardiologist F, Mx2 33, 30, 16
Total 14
GP, general practitioner.
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the COrs test
The CORS test (figure 2) has been previously described16 
and consists of four phases: (1) rest, where the patient 
lies in the supine position for 3 min; (2) challenge, where 
the patient remains in the standing position for 3 min; 
(3) and (4) stress exercise, where a patient completes a 
step test with continuous haemodynamic measurements 
(ie, cardiac output and cardiac index) using non-invasive, 
electrical signal processing technology.
Patient and public involvement
Patients/public representatives were not directly involved 
in the present qualitative study. However, their views about 
the design of the main study, which aims to assess the clin-
ical and cost effectiveness of the CORS test to improve 
diagnosis of HF in primary care, have been explored.
Data analysis
Given the exploratory nature of the present study, an 
inductive approach to data analysis was adopted. Thematic 
analysis was used because it is a flexible method that 
allowed themes to emerge freely from the data obtained.17 
All interviews were transcribed verbatim. The following 
analysis procedure was undertaken: (1) two researchers 
independently read and reread interview transcripts (SC 
and NO) in order to become adequately familiarised with 
the data; (2) both researchers independently applied 
codes to segments of data in all interview transcripts to 
develop initial themes; (3) due to the large volume of data 
generated from the interviews, several initial codes were 
generated and were later cut down to a final set agreed 
by both researchers. The final codes were collated and 
this formed the basis from which themes were conceptu-
alised. Supporting direct quotes from participants were 
subsequently selected for each theme. These were later 
discussed and approved by the research team.
results
Analysis of the data generated four themes relating to 
opportunities and challenges surrounding the imple-
mentation of the new diagnostic technology: (1) novel 
diagnostic tests are required to improve HF diagnosis; 
(2) evidence required to improve the diagnostic accuracy 
of the CORS test; (3) patient exclusion and suitability/
patient population for the CORS test and (4) financial 
implications of the CORS test within primary care.
theme 1: novel diagnostic tests are required to improve hF 
diagnosis
All GPs and consultants agreed that new diagnostic tests 
vital to improve HF diagnosis and were very positive about 
the potential role of the CORS test in primary care to aid 
diagnosis of HF and provided reasons regarding the large 
numbers of undiagnosed cases of the condition.
Personally, I think this would be a great idea, because 
I think it would be, if it’s more accurate, it would ac-
tually certainly reduce wastage in terms of referrals. 
And it would allow us to make the diagnosis much 
earlier and manage the patient based on that, real-
ly…. Well, you're talking to someone who believes 
that 70 per cent of HF is undiagnosed. And I don’t 
know what the figure is, but most HF, I believe, is cur-
rently diagnosed in the A&E (emergency admission 
unit)….So, you know, you're talking to someone who 
thinks that anything we can do which actually makes 
it easier to diagnose HF in primary care is a good 
thing. (GP, Practice 2).
Participants suggested that HF was difficult to diag-
nose with the patient often presenting with more than 
one complication or comorbidity, usually when disease 
exacerbates.
If somebody came in who had had a previous MI and 
said, ‘My ankles have swelled up. I can't lie flat in bed 
at night,’ and they had nice crackles at the bottom of 
their lungs, you would probably be right there and 
then saying, ‘I think this might be related to your 
heart,’ and so on. But sometimes it’s much less obvi-
ous. It’s just somebody presenting with breathlessness 
and it could be anything from heart failure to lung 
cancer, COPD. I mean I’m thinking of a particular 
patient who did end up having, in the end, quite se-
vere HF but it wasn’t obvious at all. (GP, Practice 3).
It was also acknowledged by secondary care partic-
ipants that in primary care HF is difficult to diagnose 
based on the limited diagnostics available in primary care 
including natriuretic peptides, which can be elevated due 
to increasing age or other comorbidities.
I think you have to see quite a high proportion of 
people who do not have HF to avoid missing it. I also 
think it’s quite a hard diagnosis in primary care be-
cause the blood tests are a very blunt tool. They’re 
great for rule out but they do not rule in. Because the 
levels go up with age, they go up with multiple comor-
bidities. Many patients who are thought to have HF, 
actually will have a raised level, even if they turn out 
not to have HF. (Consultant Cardiologist 2, Hospital 
site).
One of the Consultant Cardiologists was particularly 
sympathetic with these concerns and acknowledged that 
the point of referral was different between practices and 
noted staff ‘experience as well as knowledge and skill and confi-
dence’ play an important role in this process.
Having a simple test like the CORS test could make 
identification of patients for referrals more effective, 
thus reducing the burden on secondary care providers. 
Consultants acknowledged that they often receive many 
inaccurate referrals which led to wasted consultant time.
That’s the issue. We’re seeing too many patients who 
we don’t really need to see. If they showed me an 
echo and ECG [report], I would say, ‘I don’t need to 
see them.’ But the way it’s set up, it’s very inefficient. 
(Consultant Cardiologist 1, Hospital site).
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Although, the potential value of the CORS test in 
primary care was clear, a variety of responses were given 
regarding the designated professional to deliver the 
CORS test, that is, GPs and nurses suggested either a prac-
tice nurse or healthcare assistant. The healthcare assistant 
agreed that they could deliver this test given their expe-
rience of performing ECGs but would need practice and 
training. Practice managers suggested that nurses could 
potentially be the best person to deliver it.
For consultant cardiologists, a qualified nurse would 
be the best person to administer the test in primary care 
but others suggested local GPs practice should guide the 
selection of the most appropriate person for the delivery 
of the CORS test.
you need somebody who can say, ‘Keep going,’ but 
you also need someone to say, ‘No, stop. You look 
absolutely awful, stop.’ (Consultant Cardiologist 2, 
Hospital site).
theme 2: evidence required to improve the diagnostic 
accuracy of the COrs test
Participants highlighted the role of scientific evidence 
in implementing a pathway for the new diagnostic 
technology.
Yes. I would want to know what’s the evidence for it, 
how clear cut is the interpretation and actually, if this 
is just going to be another pre-test that is done before 
the people go, then what exactly is the role of the 
clinic. (GP, Practice 3).
Although improvements in both referral accuracy 
and patient care were considered to be important for 
secondary care clinicians, it was difficult to determine 
where the CORS test would fit in the current clinical 
care pathway without knowing its efficacy. Secondary care 
clinicians reported that the implementation of the new 
diagnostic would be less useful in secondary care with the 
patient already receiving an echocardiogram.
If it’s proven to be effective in terms of being able to 
distinguish between possible HF or refuted diagno-
sis of HF, then I think it’s useful. In terms of where 
it would fit into a pathway? Then it would appear to 
be that it would be at the start of the pathway before 
referring to secondary care. (Consultant Cardiologist 
3, Hospital site).
Successful implementation of the CORS test would 
be dependent on the confirmation of clinical and cost 
effectiveness and convincing both GP partners and 
nurses regarding the clinical need for it and the value of 
completing the test and providing good patient care.
You need more evidence, is the key bit. So it needs 
the evidence behind it. I think you might need assess-
ment through NICE to see what they think it is as an 
additional test. (Consultant Cardiologist 2, Hospital 
site).
Based on the comments from themes 1 and 2, it was 
obvious that the CORS test was vital in the primary care 
setting. Figure 1 shows a flow chart that describes the 
current clinical care pathway for the diagnosis of HF as 
adapted from the National Institute for Health and Care 
Excellence (NICE) guidelines. The potential place of the 
CORS test has been inserted into the pathway to provide 
better context of the discussion.
Theme 3: patient exclusion and suitability/patient population for 
the CORS test
A number of potential patient characteristics that could 
lead to patient exclusion were identified, for example, 
mobility, possible difficulties lying down, need of a balance 
aid, suggesting that not every patient would be suitable. 
Exercise was identified as potentially challenging. The 
number of patients who could potentially benefit from 
this technology could be increased if the duration of 
phases 3 and 4 could be reduced.
We have some patients with established HF for ex-
ample, you don’t even recommend they weigh them-
selves every day because of the safety of stepping 
on to the scales. So I think there needs that recog-
nition that some patients may not be suitable for it. 
(Consultant Cardiologist 2, Hospital site).
Other participants suggested possibility of using a set 
of parallel bars. GPs estimated a 50%–80% rate of uptake 
of the CORS test while the practice nurses were far more 
optimistic with an estimated 80% uptake.
theme 4: financial implications of the COrs test within 
primary care
A major concern raised about the implementation of the 
CORS test was on the logistics and overall cost implica-
tion of integrating the test into routine practice. Inter-
viewees were sceptical about the implementation of the 
CORS test and suggested that they would need greater 
convincing about the time needed to administer the 
test, available space, cost of equipment and the required 
training expected to deliver the test efficiently.
An additional appointment would be required to 
implement the CORS in primary care. A healthcare assis-
tant suggested an integration of the CORS test during 
the current ECG and biomarker testing appointment. 
The practice managers acknowledged that an additional 
appointment will incur an additional cost to the prac-
tice but also the availability of appointments would be a 
potential issue.
Because, it wouldn’t replace existing appointments 
[but require] additional appointments. That in it-
self adds a cost to the practice, that we would have 
to look at….That is the overall driver. You know, that 
assessment, obviously, has to be made at a partner 
and business level. The second thing, that always 
drives us, is cost. The third thing is impact on avail-
ability of appointments. Of course, it’s availability of 
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appointments is about the only thing as a practice 
we are actually measured on. (Practice Manager, 
Practice 1).
Practice managers identified the space for running 
the tests and storage of equipment as a potential issue. 
Differences in the building capacity were acknowledged 
between practices by the practice managers. A practice 
nurse suggested that the receptionists would need to be 
aware what room the equipment was in and follow similar 
booking process as for the ECG. On the contrary, it was 
suggested that a potential setting for delivery of the CORS 
could be at the community setting such as community 
diagnostic centres or outreach diagnostic facility.
 There’s increasingly, a feeling that not all practic-
es can deliver all services at all times. However, it is 
more reasonable to work to the premise that all the 
patients of all the practices should have access to all 
the tests they need. But maybe just not in their own 
building. (GP, Practice 2).
The cost of the equipment was also acknowledged as a 
potential barrier to the implementation. One approach 
to commissioning a new pathway is to incentivise primary 
care through negotiation between the primary care 
contractors and their clinical commissioning groups.
I wouldn’t expect them to supply it. I would expect 
them to fund the equipment initially. They would 
normally pass on subsequent maintenance costs 
to us. I would also expect them to commission this 
as an enhanced service. So, that we can recoup the 
manpower and equipment costs of doing it. (Practice 
Manager, Practice 1).
Training was reported as a necessity by all health-
care professionals in primary care. It was suggested that 
the professional delivering the test would need to be 
trained and the professional interpreting the results. 
For example, a healthcare assistant could deliver the test 
but a GP would interpret it, in much the same process as 
currently occurs for ECGs.
From a management perspective, my real concern is 
also how complicated the technology is. How easy it 
is for a practice nurse, who may not be using it day in 
day out to operate it?… You’ve done this test…How 
do you then get it to the doctor?. (Practice Manager, 
Practice 1).
DIsCussIOn
There has been an increase in the development and use 
of diagnostic tests in the last decade. This number will rise 
considerably taking into account the ageing population 
of developed countries and the number of people with 
chronic conditions.18 There is a clinical need to improve 
point of care diagnostic tests available in primary care, 
in particular quick and high specificity tests to diagnose 
HF. This would improve treatment and reduce inaccurate 
referrals to secondary care thus improving overall effi-
ciency and quality of care.18 The present study captured 
primary and secondary care healthcare professional’s 
perceptions for the implementation of a new diagnostic 
test. Our findings have identified the clinical role and 
potential value of the CORS test and challenges that 
would need to be addressed during the next phase of 
development of the test.
Our findings suggest that research evidence on the 
clinical value of the CORS test is vital before implemen-
tation. The CORS test is the first of its kind to attempt 
to diagnose HF in primary care and there are no studies 
to compare with; however, we are currently assessing 
the sensitivity and specificity of the CORS test which 
will provide more information for the implementation 
process.
In addition, not every patient would be suitable for to 
CORS test due to limitation of movement. We plan to 
make the CORS test accessible for the majority of patients 
entering the clinical care pathway by shortening phases 
3 and 4 and considering alternative positions (sitting or 
passive leg raise) using supporting aids during the exer-
cise phase.
Similarly, the implementation of the CORS test 
requires adequate funding and support from clin-
ical champions and commissioners. Although there 
is a general consensus that point of care tests, like the 
CORS test, increase ‘turn-around-time’ for results19 20 
and prevents additional visits to secondary care,21 the 
financial implications of the CORS test within primary 
care, such as cost of tests, space, training and time need 
to be accounted for. These challenges which has been 
reported previously22 23 may be addressed by positioning 
the CORS test within a community setting (ie, commu-
nity diagnostic centres or outreach diagnostic facility). 
This would potentially reduce the burden on the prac-
tice to deliver the test.
strengths and limitations
This is the first study to explore the opportunities and 
challenges for the implementation of the CORS test. The 
perspective of primary and secondary healthcare profes-
sionals was considered, which ensured a more reflexive 
analysis of data.24 This approach allowed the identifica-
tion of suboptimal communication between primary and 
secondary care in the current HF clinical care pathway, 
which delays diagnosis and results in inaccurate referrals 
and wasted consultant time.
Given that participants were selected only from a region 
of the North of England and in small numbers meant 
that our findings may have limited generalisation.
Data were analysed thematically using an inductive 
approach, which led to the saturation of themes at the 
analysis stage.25 However, this was the first iteration of the 
analysis of opportunities and challenges for the CORS 
test to inform further refinement of the CORS test.
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Future DIreCtIOns
After collection of the necessary evidence, an application 
to the NICE’s Diagnostic Assessment Programme will 
be attempted to increase the possibilities of widespread 
implementation and adoption in primary care.
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